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Volume 50, Number 4 Abstracts 965Table. TEVAR landing zone extension into the aortic
arch and abdominal aorta: Collateral assessment
Celiac
coverage
Patient
#
Preoperative CTA
findings
Intraoperative
angiography:
predeployment
Intraoperative
angiography:
postdeployment
Partial 1 Noncontrast CT Aortogram Patent SMA,
celiac
2 Replaced R hepatic
artery
Aortogram Patent SMA,
celiac
Complete 1 Collaterals poorly
visualized
Selective SMA
Angiogram
SMA to celiac
collaterals
2 Pancreaticoduodenal
collaterals
visualized
Aortogram SMA to celiac
collaterals
3 Chronic celiac
occlusion
Aortogram SMA to celiac
collaterals
4 Replaced R hepatic
artery
Aortogram Patent SMA,
R hepatic
CT, Computed tomography; CTA, computed tomography angiography;
R, right; SMA, superior mesenteric artery.
The Impact of Diabetes Mellitus and Renal Insufficiency on the Out-
come of Endovascular Abdominal Aortic Aneurysm Repair
Markovic JN, Rajgor D, Shortell CK
Objectives: The purpose of this study is to determine the effects of
diabetes mellitus (DM) and renal insufficiency (RI) on outcomes following
endovascular aneurysm repair (EVAR) using a very large sample size, to
assist in controlling for confounding variables.
Methods: Using the Nationwide Inpatient Sample (NIS), a nationally
representative discharge database, we retrospectively evaluated patients un-
dergoing EVAR between November 2000 and November 2005. DM and
RI were analyzed against the primary outcome variables of mortality, major
complications, length of stay (LOS), treatment cost, and routine discharge
rates. Statistical analysis was performed using generalized linear models with
normal and logistic distribution to estimate the association between EVAR
outcomes in patients with DM and RI after adjusting for confounders.
Results: A total of 12,451 patients who underwent elective EVAR
were identified. Out of these, 254 (2%) had RI, 1506 (12%) hadDM, and 48
(0.39%) had a combination of RI and DM. Patients with RI had 16 times
greater risk of mortality and were less likely (0.3 times) to be routinely
discharged when compared with patients in other three groups (Odds Ratio
[OR] 16.32; 95% Confidence Interval [CI], 4.81 - 55.306 and OR 0.301;
95% CI, 0.143 - 0.637, respectively). There was a significant difference in
LOS (RI  4.393 days, DM  2.393 days, RI  DM  4.393 days,
absent 2.393 days) and median inflation adjusted cost (RI $71,842.19,
DM  $63,055.04, RI  DM  $77,385.21, absent  $57,739.42)
among the four groups. The risk of major complications, including myocardial
infarction, transfusion, implant related complications, tracheostomy, renal com-
plications, and septicemia was 5.4, 3.1, 6.3, 25.2, 22.7 and 93.9 times higher,
respectively, in the RI group as compared with other groups studied.
Conclusions: While RI has a profound effect on outcomes following
EVAR, DM does not have a statistically significant impact on in hospital
mortality, morbidity, routine discharge rates, LOS, and inflation adjusted
cost of treatment. This study shows that RI has a greater negative influence
on the outcome of EVAR than previously suspected, and that a conservative
approach to the use of EVAR in patients with RI is warranted. DM may
confer less of a risk than previously thought, when confounders are con-
trolled for.
Carotid Endarterectomy under General Anesthesia in ASAClass 3 or 4:
A Safe Practice?
Vettukattil A, Cryer C, Macsata R, Sidawy AN
Objective: To determine if the American Society of Anesthesiology
(ASA) physical status classification negatively impacts outcomes following
carotid endarterectomy (CEA).
Methods: This is a retrospective analysis of prospectively collected data
by the Veterans Affairs National Surgical Quality Improvement Program,
January 2000 to December 2005, of all patients who underwent CEA repair
under general anesthesia. Patients with ASA class of 2, defined as mild
systemic disease, were used as the reference for comparison with higher ASA
classes: 3  severe systemic disease or 4  severe systemic disease that is a
constant threat to life. The measured outcomes included adjusted odds ratio
(OR) of death, myocardial infarction (MI), cerebrovascular accidents
(CVA), and respiratory complications. We used multiple logistic regressionto adjust for differences in demographics, operative factors, and preoperative
comorbidities.
Results: Collectively, 13,568 patients underwent CEAs with general
anesthesia. Majority of patients were white (83.0%) males (98.6%). The
percentages of patients in each ASA class were as follows: ASA 2 (5.2%), ASA
3 (78.0%), and ASA 4 (16.8%). When compared with patients with ASA 2,
unadjusted analysis of the data noted that patients with ASA 3 had an
elevated risk of respiratory complications and those with ASA 4 had an
increased risk of death, MI, CVA, and respiratory complications. However,
risk adjustment with multivariate analysis revealed no statistically significant
differences in OR for patients with ASA 3, compared with patients with ASA
2, in any of the measured outcomes: death 2.2 (0.54-9.04), MI 1.33
(0.48-3.65), CVA 1.61 (0.71-3.66), and respiratory complications 1.55
(0.68-3.54). Similarly, after risk adjustment, patients classified as ASA 4,
compared with ASA 2, had equivalent outcomes in death 3.64 (0.87-15.31),
MI 2.06 (0.72-5.92), and CVA 1.74: (0.73-4.14). Classification as ASA 4
was associated with an increase in respiratory complications 2.49 (1.07-
5.80).
Conclusion: The findings of this study suggest patients classified as
ASA 3 or 4 are as safe as those classified as ASA 2 to undergo CEA under
general anesthesia, with equivalent rates of death, CVA, and MI.
Cognitive Changes after Surgery versus Stenting for Carotid Artery
Stenosis
Lal BK, Hill J, Yunes M, Cruz G, Jamil Z
Objectives: Cognitive function has not been evaluated systematically
in the context of carotid endarterectomy (CEA) versus stenting (CAS).
Cognitive decline can occur from microembolization or hypoperfusion
during CEA or CAS. Revascularization may also improve cognitive dysfunc-
tion resulting from chronic hypoperfusion. We compared cognitive out-
comes in consecutive asymptomatic patients undergoing CAS or CEA.
Methods: This is a prospective non-randomized single-center study of
patients with asymptomatic carotid stenosis70% undergoing CAS or CEA
using standard techniques. Neurologic symptoms were evaluated by history,
physical examination, and National Institutes of Health (NIH) Stroke Scale.
A 50-minute cognitive battery was performed one to three days before and
four to six months after CEA/CAS. The tests (Trail Making Test A/B,
Processing Speed Index-PSI, Boston Naming Test, Working Memory In-
dex-WMI, Controlled Oral Word Association, and California Verbal Learn-
ing Test) for five cognitive domains (learning/memory, attention, psy-
chomotor speed, motor speed/coordination, and verbal fluency) were
conducted by a neuropsychologist. The primary analysis of impact of treat-
ment modality was a cognitive change-score.
Results: Forty-six patients underwent pre-post testing (CEA  25,
CAS  21). Thirty-six percent were women; mean pre-procedural stenosis
was 84%; 54% were right-sided lesions. All patients were successfully revas-
cularized without peri-procedural complications. The scores for each test
improved after CEA except WMI which decreased in 20/25 patients.
Improvement occurred in all tests after CAS except PSI which decreased in
18/21 patients. Overall cognitive change was measured by calculating the
change in composite cognitive score (CCS) vs baseline. The raw scores from
each test were transformed into a z-score to calculate each patient’s baseline
composite score. The CCS improved after CEA and CAS, and the changes
were not significantly different between the groups (.51 vs .47 SD, P ns).
Conclusions: Carotid revascularization results in an overall improve-
ment in cognitive function. There are no differences in the composite scores
of five major cognitive domains between CEA and CAS. When individual
tests are compared, CEA results in a reduction in memory, while CAS
patients show reduced psychomotor speed. Larger studies are required to
confirm these findings.
Carotid Endarterectomy for Asymptomatic Disease: Does Degree of
Stenosis Influence Outcome?
Darling RC, Roddy SO, Paty PSK, et al
Objectives: Carotid endarterectomy (CEA) for asymptomatic carotid
bifurcation disease has dramatically increased since publication of the
Asymptomatic Carotid Atherosclerosis Study (ACAS). In this report, males
with 60% or greater stenosis had a significant decrease in stroke with surgical
over medical therapy when survival exceeded five years. However, many
physicians wait until patients achieve 70% or even 80% stenosis before
referring patients for surgery. In this study, we evaluate our results in
asymptomatic patients undergoing CEA and stratify them according to
percent stenosis.
Methods:We retrospectively reviewed our vascular registry on asymp-
tomatic patients undergoing CEA since 1994. Patients were by to percent
stenosis and grouped into categories: 60%-69%, 70%-79%, 80%-89%, and
90%-99%. Results were analyzed in regard to neurologic deficit and periop-
erative mortality. Patients undergoing combined coronary/carotid proce-
dures were excluded from analysis.
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tomatic disease; 102 (2%) for stenoses of 60%-69%, 758 (12%) of 70%-79%
stenosis, 2263 (35%) for 80%-89% stenosis, and 3281 (51%) for 90%-99%
stenosis. Risk factors were similar in all groups. Shunt utilization was higher
in the 60%-69% stenosis group than the others. In the 60%-69% group there
were no strokes and no deaths, in the 70%-79% group there were two (0.3%)
deaths and two (0.6%) strokes. In the 80%-89% group there were 12 (0.5%)
deaths, 11 permanent neurologic deficits, and two temporary neurologic
deficits (0.6%). In the 90%-99% group, there were 23 (0.7%) mortalities, five
(0.2%) temporary neurological deficits (TND), and nine (0.3%) permanent
strokes. The most common non-neurologic complication was postoperative
hematoma at 1.4% and was consistent throughout all groups. Mean fol-
low-up averaged 48 months.
Conclusions: Patients presenting with moderate 60% to 69% stenoses
can be treated safely with carotid endarterectomy. All asymptomatic patients
over 60% stenosis had an acceptably low mortality and morbidity in this
series.
Durability of Infrainguinal Interventions in Patients with Severely
Disabling Claudication and TASC II C and D Femoropopliteal Disease
Dosluoglu HH, Lall P, Harris LM, Dryjski ML
Objectives: Durability of open and endovascular interventions on
patients with disabling claudication is a major concern, especially in those
with complex anatomy needing infrainguinal reconstructions. The goal of
our study was to compare our results of bypass versus endovascular inter-
ventions in a consecutive patient series and to determine effectiveness of
treatment modality.
Methods: All patients who presented with severely disabling claudica-
tion (Rutherford 3) with TASC II C or D disease, who underwent bypass, or
infrainguinal endovascular (EV) interventions following failure of medical
management between June 2001 and December 2008 were included.
Results:There were 56 patients in the EV group, and 56 patients in the
open group. The comorbidities were similar, except there were more active
smokers (68% vs. 46%, P .035) and prior ipsilateral revascularizations (38%
vs. 7%, P  .001) in the open group. Fifty-nine percent of bypasses were
performed using polytetrafluoroethylene (PTFE). There were no 30-day
postoperative mortalities. There were four superficial infections, one deep
infection (necessitating graft removal), and one perigraft seroma in the open
group. Technical success was 95% in the EV group. Length of stay was
significantly less in the EV group (1.0  1.3 vs. 5.1  4.1 days, P  .001).
The mean ankle-brachial index (ABI) increased from 0.55 to 0.94, similar in
both groups. The mean follow-up was 29 22 months. Primary, secondary
patency, sustained clinical success rates (clinical improvement, freedom from
target extremity revascularization (TER]), secondary clinical success (with
TER) were similar (Table I), with a 36-month survival rate of 91 4%. Only
one patient had an amputation in the open group at 32 months. Fifteen
patients (27%) in open and 20 patients (36%) in EV group required ipsilat-
eral reinterventions (Table II; P  .419).
Conclusions: Clinical benefit following endovascular and open inter-
ventions in patients with severely disabling claudication and TASC II C or D
femoropopliteal disease is similar at three years. The clinical improvement
without additional procedures is achieved only in half, and TER is required
in about a third of the patients. Aggressive medical management of claudi-
cation is warranted before any (open or endovascular) interventions are
planned, and patients should be informed of the expected outcomes.
Table I. Patency rates and sustained and secondary
clinical success rates
PP SP SusClSuc SecClSuc
12 mo 36 mo 12 mo 36 mo 12 mo 36 mo 12 mo 36 mo
Open 79%  6% 59%  8% 82%  6% 71%  8% 77%  6% 58%  8% 85%  5% 75%  7%
EV 69%  7% 54%  8% 86%  5% 69%  9% 67%  7% 48%  8% 92%  4% 80%  8%
P .162 .942 .120 .387
EV, Endovascular; PP, primary patency; SecCLSuc, secondary clinical suc-
cess; SP, secondary patency; SusClSuc, sustained clinical success.Table II. Reinterventions in open and EV-treated groups
Reinterventions Open EV
Thrombolysis  PTA/S 6 8
Repeat bypass 5 7
EV recanalization 2 1
Inflow/runoff EV intervention 2 8
Contralateral revascularization 5 7
Contralateral amputation 2 0
EV, Endovascular; PTA/S, percutaneous transluminal angioplasty/stent.
Salvage after Failed Surgical Bypass: Effectiveness of Endovascular
Recanalization of Native Lower Extremity Arterial Occlusions
Dayal R , Graham AR , Khan H, et al
Objectives:The purpose of this study was to determine the outcome of
endovascular interventions of the native circulation after failed lower extrem-
ity bypass grafting.
Methods: A prospective registry encompassing all patients treated for
lower extremity atherosclerotic disease from May 2004 to September 2008
was established. Patients were followed with duplex ultrasound and ankle-
brachial index/pulse volume recording (ABI/PVR) at one, three, six, and
12 months and annually. Patients treated after failed lower extremity bypass
grafting were identified and angiogram, duplex, and ABI data abstracted.
Patients with similar comorbidities and lesion characteristics not treated with
prior bypass grafting were used as comparison. Statistical analysis was per-
formed using Kaplan-Meier and log-rank analysis.
Results: One thousand nine hundred and thirty eight lower extremity
arterial lesions were treated in 826 patients. Seventy-four arterial lesions in 39
patients were treated in those who had undergone prior bypass grafting (BPG).
Indications were claudication (n  16, 38.5%), rest pain (n  8, 17.9%), and
tissue loss (n  15, 43.6%). Prior bypass were femoral to popliteal (71.8%),
femoral to tibial (25.6%), and external iliac to popliteal (2.6%). Mean follow-up
was 13.7 11.5months. Comparison to a corresponding group of non-bypass
graft patients (NBPG) revealed that there was no significant difference in
primary, assisted primary, secondary patencies, or limb salvage in patients
treated with prior BPG (Table I) when the indication for treatment was critical
limb ischemia (CLI). In contrast, comparison to a corresponding group of
NBPG revealed that there was significant decrease in primary, assisted primary,
and secondary patency in patients treated with prior BPG (Table II) when the
indication for treatment was claudication. This difference persisted even when
corrected for comorbidities and lesion characteristics. Lesion length, percent
stenosis, and percent chronic total occlusion were 162.7 139.7 and 130.3
56.9 (P .21), 88.4 11.0 and 90.1 12.1 (P .47), 34.4% and 49.7% (P
.12) for BPG and NBPG lesions, respectively.
Conclusions: Endovascular salvage of native arterial occlusions after
failed surgical bypass achieves acceptable patency and limb salvage in patients
with CLI. Conversely, patients with claudication that are subsequently
treated with endovascular methods have poor long-term patency and require
multiple endovascular interventions to maintain patency.
Table I. Patency and limb salvage rates in CLI patients
treated with endovascular modalities
6 mo 12 mo 18 mo 24 mo 30 mo
Primary patency BPG 74.6  7.3 51.2  8.9 33.4  9.3 33.4  9.3 11.1  9.6
Primary patency
No BPG
69.2  3.7
P  .59
51.0  4.4
P  .95
42.1  4.6
P  .68
35.2  4.8
P  .860
35.2  4.8
P  .556
Primary assisted
patency BPG
83.2  6.3 58.8  9.0 49.3  9.8 49.3  9.8 49.3  9.8
Primary assisted
patency
No BPG
73.0  3.6
P  .26
60.3  4.3
P  .90
53.1  4.7
P  .98
45.6  5.1
P  .78
43.7  5.2
P  .74
Secondary patency
BPG
83.1  6.3 72.0  8.1 61.3  9.8 61.3  9.8 61.3  9.8
Secondary patency
No BPG
78.2  3.3
P  .57
71.7  3.9
P  .88
64.5  4.5
P  .95
57.9  5.1
P  .86
55.9  5.3
P  .82
Limb salvage BPG 85.4  6.0 76.9  7.9 76.9  7.9 76.9  7.9 76.9  7.9
Limb salvage
No BPG
86.1  2.8
P  .89
80.2  3.5
P  .75
77.6  3.9
P  .88
75.4  4.4
P  .94
71.9  5.4
P  .98
BPG, Bypass grafting; CLI, critical limb ischemia.
